OncLive® Scientific Interchange and Workshop Podcast Series: Management of HER2+ Breast Cancer - Episode 9

Updates and Advances in the Treatment of Metastatic HER2+ Breast Cancer

Dr Pegram and colleagues focus on key clinical trials such as DESTINY-Breast01, HER2CLIMB, NALA, and SOPHIA in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.